Nonetheless, our report demonstrates that Gαi2 and Src are needed for HIF1α activation in hypoxic conditions, indicating that inhibition of this pathway can suppress hypoxia-induced resistance in ovarian cancer patients. Here, SRC is linked to ovarian cancer.